针对性单克隆抗体在神经脊髓炎光学谱系障碍中的新兴作用
Angela H Holian1, Brian G Weinshenker2
1Department of Neurology, UVA Specialty Pharmacy, University of Virginia, 1221 Lee Street, 4th Floor PCC, Charlottesville, VA, 22908, USA. arh6j@uvahealth.org.
概括
新的单克隆抗体 (mAbs) 为AQP4-IgG血清阳性患者提供有效的NMOSD治疗,显著降低攻击频率. 本综述详细介绍了它们的疗效,安全性和与旧疗法相比的使用情况.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 视神经炎光谱障碍 (NMOSD) 是一种严重的自身免疫性疾病,影响视神经和脊髓.
- 自20世纪90年代末以来,传统的免疫抑制疗法一直是NMOSD的标准治疗方法.
研究的目的:
- 审查新批准的单克隆抗体 (mAbs) 在管理NMOSD中的作用.
- 将这些mAbs的疗效,安全性和作用机制与rituximab和传统免疫抑制剂进行比较.
主要方法:
- 对AQP4-IgG-阳性NMOSD的四种已批准的mAbs的最新文献的审查:eculizumab,inebilizumab,satralizumab和ravulizumab.
- 针对性免疫调节疗法的比较分析与传统的免疫抑制剂和rituximab.
主要成果:
- 四种mAbs (eculizumab,inebilizumab,satralizumab,ravulizumab) 已被FDA批准用于AQP4-IgG-阳性NMOSD. 这四种药物被FDA批准用于AQP4-IgG-阳性NMOSD.
- 这些向疗法有效地减少了AQP4-IgG血清阳性患者的NMOSD攻击频率.
结论:
- 单克隆抗体代表了NMOSD管理的转型方法.
- 讨论包括治疗选择,临床挑战 (坚持,监测,成本,获取) 和管理治疗失败.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Myasthenia Gravis: Diagnostic Tests
699
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
699


